Cargando…

Immunomodulation in Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is an aggressive disease that has few options for treatment. Immune checkpoint blockers have been revolutionary in specific cancer types yet have not shown promise in pancreatic cancers. This review discusses components of the immune system needed for successful ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnamoorthy, Mithunah, Lenehan, John G., Burton, Jeremy P., Maleki Vareki, Saman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696309/ https://www.ncbi.nlm.nih.gov/pubmed/33198059 http://dx.doi.org/10.3390/cancers12113340

Ejemplares similares

Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy
por: Gholami, Hasti, et al.
Publicado: (2023)

Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer
por: Vareki, Saman Maleki, et al.
Publicado: (2018)

The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer
por: Aghamajidi, Azin, et al.
Publicado: (2022)

Enhanced donor screening for faecal microbial transplantation during COVID-19
por: Parvathy, Seema Nair, et al.
Publicado: (2021)

High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
por: Maleki Vareki, Saman
Publicado: (2018)

Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
por: Hong, Megan M Y, et al.
Publicado: (2022)

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma
por: Deluce, Jasna, et al.
Publicado: (2022)

Emerging Biomarker-Guided Therapies in Prostate Cancer
por: Deluce, Jasna E., et al.
Publicado: (2022)

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines
por: Maleki Vareki, Saman, et al.
Publicado: (2018)

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
por: Salim, Kowthar Y., et al.
Publicado: (2016)

Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases
por: Badiuk, Sawyer Rhae, et al.
Publicado: (2022)

HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct
por: Evans, Andris M., et al.
Publicado: (2022)

Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
por: Salim, Kowthar Y., et al.
Publicado: (2017)

Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma
por: Ninkov, Marina, et al.
Publicado: (2022)

Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma
por: Cardenas, Luisa M., et al.
Publicado: (2022)

The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer
por: Naqash, Abdul Rafeh, et al.
Publicado: (2021)

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
por: Gameiro, Steven F., et al.
Publicado: (2018)

Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”
por: Rytelewski, Mateusz, et al.
Publicado: (2013)

Cancer-associated adipocytes as immunomodulators in cancer
por: Wu, Qi, et al.
Publicado: (2021)

Immunomodulators for Asthma
por: Dimov, Vesselin V, et al.
Publicado: (2010)

Schistosome immunomodulators
por: Acharya, Sreemoyee, et al.
Publicado: (2021)

The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention(*)
por: Jazi, Seyed Mohammad Hashemi, et al.
Publicado: (2011)

Cancer immunomodulation using bispecific aptamers
por: Thomas, Brian J., et al.
Publicado: (2022)

Antiviral and Immunomodulation Effects of Artemisia
por: Kshirsagar, Suhas G., et al.
Publicado: (2021)

Role of chemotherapeutic drugs in immunomodulation of cancer
por: Mukherjee, Oishi, et al.
Publicado: (2023)

Lymphatics in Tumor Progression and Immunomodulation
por: Li, Claire Y., et al.
Publicado: (2022)

A Review of the Role of Wnt in Cancer Immunomodulation
por: Goldsberry, Whitney N., et al.
Publicado: (2019)

Highlights of Immunomodulation in Salmonella-Based Cancer Therapy
por: Pangilinan, Christian R., et al.
Publicado: (2021)

Small molecule-based immunomodulators for cancer therapy
por: Wu, Yinrong, et al.
Publicado: (2022)

The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis
por: Basson, Charlise, et al.
Publicado: (2023)

The inflammasome in biomaterial‐driven immunomodulation
por: Vasconcelos, Daniela P., et al.
Publicado: (2022)

EVALUATING HUMAN MICROBIOME SIGNATURES ASSOCIATED WITH DEVELOPMENT, OUTCOME, AND TREATMENT RESPONSE IN GLIOMA AND BRAIN METASTASIS: A SCOPING REVIEW
por: Leigh, J, et al.
Publicado: (2023)

Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization
por: Thyagarajan, Anita, et al.
Publicado: (2017)

Autophagy-Mediated Exosomes as Immunomodulators of Natural Killer Cells in Pancreatic Cancer Microenvironment
por: Papademetrio, Daniela L., et al.
Publicado: (2021)

Immunomodulation and Disease Tolerance to Staphylococcus aureus
por: Li, Zhigang, et al.
Publicado: (2015)

Immunomodulators in the Rheumatic Diseases
por: Evans, Janine
Publicado: (1991)

Immunomodulating compounds in Basidiomycetes
por: Mizuno, Masashi, et al.
Publicado: (2013)

Immunomodulators in chronic rhinosinusitis
por: Lavigne, Philippe, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5858c3cmgkqsgqpjqm7h812cc1